Artykuły (wybrane): Strauss, L.; Bergmann, C.; Szczepański, M.; Gooding, W.; Johnson, J.T.; Whiteside, T.L. A Unique Subset of CD4+CD25highFoxp3+ T Cells Secreting Interleukin-10 and Transforming Growth Factor-Β1 Mediates Suppression in the Tumor Microenvironment. Clin. Cancer Res. 2007, 13, 4345–4354, doi:10.1158/1078-0432.CCR-07-0472. Strauss, L.; Bergmann, C.; Szczepański, M.J.; Lang, S.; Kirkwood, J.M.; Whiteside, T.L. Expression of ICOS on Human Melanoma-Infiltrating CD4+CD25highFoxp3+ T Regulatory Cells: Implications and Impact on Tumor-Mediated Immune Suppression. J. Immunol. 2008, 180, 2967–2980, doi:10.4049/JIMMUNOL.180.5.2967. Hofmann, L.; Harasymczuk, M.; Huber, D.; Szczepański, M.J.; Dworacki, G.; Whiteside, T.L.; Theodoraki, M.N. Arginase-1 in Plasma-Derived Exosomes as Marker of Metastasis in Patients with Head and Neck Squamous Cell Carcinoma. Cancers (Basel). 2023, 15, doi:10.3390/CANCERS15225449. Visus, C.; Wang, Y.; Lozano-Leon, A.; Ferris, R.L.; Silver, S.; Szczepanski, M.J.; Brand, R.E.; Ferrone, C.R.; Whiteside, T.L.; Ferrone, S.; et al. Targeting ALDHbright Human Carcinoma–Initiating Cells with ALDH1A1-Specific CD8+ T Cells. Clin. Cancer Res. 2011, 17, 6174–6184, doi:10.1158/1078-0432.CCR-11-1111. Lee, D.H.; Szczepanski, M.;